Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 9/20 | 0.41 |
| ▸ | ACHE | P22303 | 6/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | GPR3 | P46089 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL16700231 | 0.88 | HTT (0.46) | KCNH2ACHEHTTGPR3 | |
| SCHEMBL29251851 | 0.85 | HTT (0.44) | ACHEHTTKDM4E | |
| Sulfuric Acid SCHEMBL21195058 | 0.85 | HTT (0.44) | ACHEHTTKDM4EMAPT | |
| Trifluoromethanesulfonic Acid SCHEMBL3176659 | 0.85 | HTT (0.56) | KCNH2ACHEHTTKDM4EMAPT | |
| Trifluoromethanesulfonic Acid SCHEMBL6522138 | 0.84 | KCNH2 (0.40) | KCNH2ACHEHTTGPR3 | |
| Sulfuric Acid SCHEMBL21195059 | 0.83 | HTT (0.42) | ACHEHTTKDM4EMAPT | |
| Trifluoromethanesulfonic Acid SCHEMBL29252670 | 0.82 | HTT (0.67) | KCNH2ACHEHTTKDM4EMAPT | |
| Trifluoromethanesulfonic Acid SCHEMBL30330730 | 0.82 | HTT (0.67) | KCNH2ACHEHTTKDM4EMAPT | |
| Trifluoromethanesulfonic Acid SCHEMBL29251997 | 0.82 | HTT (0.67) | KCNH2ACHEHTTKDM4EMAPT | |
| Trifluoromethanesulfonic Acid SCHEMBL29251955 | 0.82 | HTT (0.67) | KCNH2ACHEHTTKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3244987-B1 | SEPARATIONS WITH IONIC LIQUID SOLVENTS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2022-06-22 | — | — | EP | claimed |
| CN-107427758-B | Separation using ionic liquid solvents | 切弗朗菲利浦化学公司 | 2020-11-20 | — | — | CN | claimed |
| EP-3244987-A1 | SEPARATIONS WITH IONIC LIQUID SOLVENTS | Chevron Phillips Chemical Company LP (US) | 2017-11-22 | — | — | EP | claimed |
| US-20150133711-A1 | Separations With Ionic Liquid Solvents | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2015-05-14 | — | — | US | claimed |
| EP-1658268-B1 | MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS | NOVARTIS AG (CH) | 2014-02-12 | — | — | EP | claimed |
| WO-2023046704-A1 | ELECTROCHEMICAL GAS SENSOR AND ELECTROLYTE FOR AN ELECTROCHEMICAL GAS SENSOR | Dräger Safety AG & Co. KGaA (DE) | 2023-03-30 | — | — | WO | disclosed |
| EP-4155723-A1 | ELECTROCHEMICAL GAS SENSOR AND ELECTROLYTE FOR AN ELECTROCHEMICAL GAS SENSOR | Dräger Safety AG & Co. KGaA (DE) | 2023-03-29 | — | — | EP | disclosed |
| EP-3244987-B1 | SEPARATIONS WITH IONIC LIQUID SOLVENTS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2022-06-22 | — | — | EP | disclosed |
| EP-3042939-B1 | ADHESIVE COMPOSITION | TOAGOSEI CO LTD (JP) | 2021-06-23 | — | — | EP | disclosed |
| CN-109415602-B | 2-cyanoacrylate-based adhesive composition | 东亚合成株式会社 | 2021-05-25 | — | — | CN | disclosed |
| CN-107427758-B | Separation using ionic liquid solvents | 切弗朗菲利浦化学公司 | 2020-11-20 | — | — | CN | disclosed |
| US-10793749-B2 | 2-cyanoacrylate-based adhesive composition | TOAGOSEI CO., LTD. (JP) | 2020-10-06 | — | — | US | disclosed |
| US-20150315426-A1 | ADHESIVE COMPOSITION | TOAGOSEI CO., LTD. (JP) | 2015-11-05 | — | — | US | disclosed |
| EP-2933302-A1 | ADHESIVE COMPOSITION | Toagosei Co., Ltd (JP) | 2015-10-21 | — | — | EP | disclosed |
| US-20150133711-A1 | Separations With Ionic Liquid Solvents | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2015-05-14 | — | — | US | disclosed |
| EP-1658268-B1 | MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS | NOVARTIS AG (CH) | 2014-02-12 | — | — | EP | disclosed |
| US-7691180-B2 | Mixtures of ionic liquids with lewis acids | NOVARTIS AG (CH) | 2010-04-06 | — | — | US | disclosed |
| US-20060264642-A1 | Mixtures of ionic liquids with lewis acids | NOVARTIS AG (CH) | 2006-11-23 | — | — | US | disclosed |
| EP-1658268-A1 | MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS | Novartis AG (CH) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005014547-A1 | MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS | NOVARTIS AG (CH) | 2005-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264642-A1 | Mixtures of ionic liquids with lewis acids | NRAS, KRAS, SSB | KCNH2 2217/4885ACHE 4215/4885HTT 3445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.